Philips introduces DreamWisp to growing portfolio of sleep solutions
April 01 2019 - 9:00AM
Philips introduces DreamWisp to growing portfolio of sleep
solutions
April 1, 2019
- Over-the-nose nasal cushion with the hose on top of the head to
offer unprecedented comfort for CPAP mask users
- First-of-its-kind solution for sleep apnea patients allows them
to sleep in any position they want
Amsterdam, the Netherlands – Royal Philips
(NYSE: PHG, AEX: PHIA), a global leader in health technology, today
announced the launch of DreamWisp, the first-of-its-kind
over-the-nose nasal mask that allows patients with sleep apnea to
sleep in any position they want. With its robust nasal cushion and
top-of-the-head tube design, DreamWisp delivers a new level of
comfort and freedom of movement, providing patients with the
therapy option that best suits their needs.
More than 100 million people are estimated to suffer from
obstructive sleep apnea (OSA) worldwide [1]. Unfortunately, many of
these patients with sleep apnea have difficulty adhering to their
therapy because of the discomfort associated with CPAP masks. For
those who need an over-the-nose mask, the front facial tube is
often cited as the main reason why patients chose to forgo sleep
apnea treatment. The DreamWisp mask solves this problem by bringing
the benefit of Philips DreamWear’s unique top-of-the-head tube
design to users who benefit from the seal of an over-the-nose
cushion, yet continue to deal with the challenges of frontal
tubing. With this CPAP mask, patients now have the option to apply
an over the-nose cushion to their DreamWear masks, providing an
extra level of comfort and the opportunity to improve therapy
adherence.
“Throughout the world, millions of people suffer from sleep
apnea and many of them struggle to adhere to therapy because of
mask discomfort,” said Mark D’Angelo, Sleep Business Leader for
Philips. “Designed with the patient in mind, DreamWisp helps sleep
apnea patients get the rest they deserve with the ability to sleep
more comfortably. As we continue to expand our sleep portfolio, our
focus remains on providing patients with comfortable solutions that
help them improve their sleep and overall wellbeing.”
As a leader in sleep apnea mask design, Philips has been
innovating for years based on provider and patient feedback. In
fact, 97 % of clinicians participating in a trial said they would
recommend the DreamWisp mask to another clinician [2]. In addition,
DreamWisp patients and their bed partners alike said they were
satisfied with the exhalation of air from the mask, commenting both
on the ability of the mask to stay in place and to maintain its
seal [3].
The development of DreamWisp expands on Philips’ commitment to
improving the quality of life for those with sleep and respiratory
conditions. The Philips DreamWisp mask is now available for
purchase through Philips-authorized home medical equipment
providers and online medical equipment providers.
For additional information on Philips’ solutions for sleep and
respiratory care, follow @PhilipsResp on Twitter or visit
www.philips.com/DreamWisp-news.
[1] The Official STOP-BANG Questionnaire. Retrieved
from http://www.stopbang.ca/osa/prevalence.php. [2] April
2018 Clinician Ease of Use trial, n=30[3] Users study; patient
preference study n=52, March/April 2018, both at 10 and 30 days
For further information, please contact:
Kathy O'Reilly Philips Group Press Office Tel: +1
978-659-2638 E-mail: kathy.oreilly@philips.comTwitter:
@kathyoreilly
Meredith Amoroso Philips Sleep and Respiratory Care Tel: +1
724-584-8991
E-mail: meredith.amoroso@philips.com
About Royal PhilipsRoyal Philips (NYSE: PHG,
AEX: PHIA) is a leading health technology company focused on
improving people's health and enabling better outcomes across the
health continuum from healthy living and prevention, to diagnosis,
treatment and home care. Philips leverages advanced technology and
deep clinical and consumer insights to deliver integrated
solutions. Headquartered in the Netherlands, the company is a
leader in diagnostic imaging, image-guided therapy, patient
monitoring and health informatics, as well as in consumer health
and home care. Philips generated 2018 sales of EUR 18.1 billion and
employs approximately 77,000 employees with sales and services in
more than 100 countries. News about Philips can be found at
www.philips.com/newscenter.
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Sep 2023 to Sep 2024